Donor leukocyte transfusions for leukemic relapse.

Keyphrases

• Leukocytes 100%
• Marrow 100%
• Transfusion 100%
• Leukemic Relapse 100%
• Chronic Myeloid Leukemia 80%
• Leukemia 60%
• Aplasia 60%
• Remission 40%
• Interferon-α (IFN-α) 40%
• Hematopoietic Cells 40%
• Specific Antigen 40%
• Advanced Stage 20%
• Lymphocytes 20%
• Good Quality 20%
• Cell Surface 20%
• Chronic Phase 20%
• Major Complications 20%
• Effector Cells 20%
• Graft-versus-host Disease (GvHD) 20%
• Acute Lymphoblastic Leukemia 20%
• Bone Marrow Transplantation 20%
• Acute Myeloid Leukemia 20%
• Myelodysplastic Syndrome 20%
• Hematopoiesis 20%
• Target Antigen 20%
• Graft-versus-leukemia Effect 20%
• Relapse Rate 20%
• Acute Leukemia 20%
• Minor Histocompatibility Antigens 20%
• Concomitant Treatment 20%
• Effector Target 20%
• Conditioning Treatment 20%
• Graft-versus-host Reaction 20%
• Histocompatibility Antigens 20%
• Best Time 20%

Medicine and Dentistry

• Chronic Myelogenous Leukemia 100%
• Leukocyte Transfusion 100%
• Aplasia 75%
• Leukemia 75%
• Recurrent Disease 50%
• Hematopoietic Cell 50%
• Antigen Specificity 50%
• Interferon Alfa 50%
• Leukemia Remission 50%
• Graft Versus Host Reaction 50%
• Conditioning 25%
• Infusion 25%
• Recurrence Risk 25%
• Effector Cell 25%
• Cell Surface 25%
• Acute Lymphoblastic Leukemia 25%
• Bone Marrow Transplantation 25%
• Myelodysplastic Syndrome 25%
• Acute Myeloid Leukemia 25%
• Minor Histocompatibility Antigen 25%
• Graft Versus Leukemia Effect 25%
• Acute Leukemia 25%
• Histocompatibility Antigen 25%
• Hematopoiesis 25%
• Lymphocyte 25%